Stock TRP TISSUE REPAIR LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Tissue Repair Ltd

Equities

TRP

AU0000180887

Delayed Australian S.E.
Other stock markets
 10:45:58 2024-06-06 pm EDT 		5-day change 1st Jan Change
0.22 AUD 0.00% Intraday chart for Tissue Repair Ltd -4.35% 0.00%
Feb. 29 Tissue Repair Limited Announces Change of Company Secretary CI
Feb. 28 Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tissue Repair Limited Announces Change of Company Secretary
CI
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Tissue Repair Secures Third US Patent for Glucoprime Compound
MT
17,604,240 Options of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.
CI
13,684,488 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.
CI
Tissue Repair Ltd Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Tissue Repair Limited Announces Company Secretary Changes
CI
Tissue Repair Secures US FDA Clearance for Phase Three Leg Ulcer Trial
MT
Tissue Repair Ltd Appoints Michael Silberberg as Director
CI
Tissue Repair Ltd Announces Board Resignations
CI
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2022
CI
Tissue Repair to Test TR-987 Drug in 2023
MT
Tissue Repair Ltd Announces Change of Company Secretary
CI
Tissue Repair Limited Announces That It Has Received Responses to the Matters Raised in the Type C Meeting That the Company Submitted to the FDA on June 29, 2022
CI
Tissue Repair Secures Second US Patent for Use of Active Ingredient in Skin Conditions
MT
Tissue Repair Limited to Enter a Phase 3 Program in Venous Leg Ulcers
CI
BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
AQ
3,770,440 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 30-APR-2022.
CI
Australian Shares Fall Amid Global Selloff as Russia Continues Assault on Ukraine
MT
Tissue Repair Secures US Patent Approval for Wound Drug; Shares Sink 8%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRP Stock
  4. News Tissue Repair Ltd